nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Entacapone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Entacapone—Discomfort—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Entacapone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Entacapone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Entacapone—Angioedema—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Entacapone—Angioedema—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Entacapone—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Entacapone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Entacapone—Malaise—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Entacapone—Malaise—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Entacapone—Oedema—Triamcinolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Entacapone—Vertigo—Dexamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Entacapone—Vertigo—Betamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Entacapone—Syncope—Dexamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Entacapone—Syncope—Betamethasone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Entacapone—Sweating—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Entacapone—Haematuria—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Entacapone—Shock—Triamcinolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Entacapone—Insomnia—Prednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Entacapone—Alopecia—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Entacapone—Shock—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Entacapone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Entacapone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Entacapone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Entacapone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Entacapone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Entacapone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Entacapone—Mental disorder—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Entacapone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Entacapone—Malnutrition—Prednisone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Entacapone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Entacapone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Entacapone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Entacapone—Convulsion—Dexamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Entacapone—Convulsion—Betamethasone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Entacapone—Hypertension—Betamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Entacapone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Entacapone—Myalgia—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Entacapone—Myalgia—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Entacapone—Anxiety—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Entacapone—Anxiety—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Entacapone—Discomfort—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Entacapone—Discomfort—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Entacapone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Entacapone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Entacapone—Pain—Prednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Entacapone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Entacapone—Hepatitis—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Entacapone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Entacapone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Entacapone—Vision blurred—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Entacapone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Entacapone—Oedema—Betamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Entacapone—Oedema—Dexamethasone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Entacapone—Insomnia—Triamcinolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Entacapone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Entacapone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Entacapone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Entacapone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Entacapone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Entacapone—Visual impairment—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Entacapone—Shock—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Entacapone—Shock—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Entacapone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Entacapone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Entacapone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Entacapone—Agitation—Prednisone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Entacapone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Entacapone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Entacapone—Angioedema—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Entacapone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Entacapone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Entacapone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Entacapone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Entacapone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Entacapone—Malaise—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Entacapone—Vertigo—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Entacapone—Eye disorder—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Entacapone—Syncope—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Entacapone—Anorexia—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Entacapone—Anorexia—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Entacapone—Urticaria—Prednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Entacapone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Entacapone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Entacapone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Entacapone—Pain—Triamcinolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Entacapone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Entacapone—Hypotension—Betamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Entacapone—Hypotension—Dexamethasone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Entacapone—Convulsion—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Entacapone—Hypertension—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Entacapone—Myalgia—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Entacapone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Entacapone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Entacapone—Anxiety—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Entacapone—Alopecia—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Entacapone—Insomnia—Betamethasone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Entacapone—Insomnia—Dexamethasone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Entacapone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Entacapone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Entacapone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Entacapone—Discomfort—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Entacapone—Malnutrition—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Entacapone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Entacapone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Entacapone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Entacapone—Urticaria—Triamcinolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Entacapone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Oedema—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Entacapone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Entacapone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Entacapone—Back pain—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Entacapone—Fatigue—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Entacapone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Entacapone—Shock—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Entacapone—Pain—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Entacapone—Pain—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Entacapone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Entacapone—Skin disorder—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Entacapone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Entacapone—Anorexia—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Entacapone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Entacapone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Entacapone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Entacapone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Entacapone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Entacapone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Entacapone—Malaise—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Entacapone—Vertigo—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Entacapone—Urticaria—Dexamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Entacapone—Urticaria—Betamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Entacapone—Dizziness—Prednisolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Entacapone—Asthenia—Triamcinolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Insomnia—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Entacapone—Paraesthesia—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Entacapone—Pruritus—Triamcinolone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Entacapone—Cough—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Entacapone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Entacapone—Convulsion—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Entacapone—Dyspepsia—Prednisone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Entacapone—Chest pain—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Entacapone—Myalgia—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Entacapone—Decreased appetite—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Entacapone—Rash—Prednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Entacapone—Dermatitis—Prednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Entacapone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Entacapone—Fatigue—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Entacapone—Headache—Prednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Entacapone—Discomfort—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Entacapone—Constipation—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Entacapone—Confusional state—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Entacapone—Dizziness—Triamcinolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Entacapone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Entacapone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Entacapone—Asthenia—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Entacapone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Entacapone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Entacapone—Nausea—Prednisolone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Entacapone—Pruritus—Dexamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Entacapone—Pruritus—Betamethasone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Entacapone—Vomiting—Triamcinolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Entacapone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Entacapone—Rash—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Anorexia—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Rash—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Urticaria—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Headache—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Entacapone—Headache—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Entacapone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Entacapone—Body temperature increased—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Entacapone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Entacapone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Entacapone—Hypotension—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Entacapone—Dizziness—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Entacapone—Dizziness—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Entacapone—Insomnia—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Entacapone—Nausea—Triamcinolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Entacapone—Nausea—Methylprednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Entacapone—Somnolence—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Entacapone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Entacapone—Vomiting—Betamethasone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Entacapone—Vomiting—Dexamethasone—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000995	0.000995	CcSEcCtD
Entacapone—Rash—Betamethasone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Entacapone—Rash—Dexamethasone—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Entacapone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Entacapone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000988	0.000988	CcSEcCtD
Entacapone—Fatigue—Methotrexate—ankylosing spondylitis	0.000987	0.000987	CcSEcCtD
Entacapone—Headache—Betamethasone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Entacapone—Headache—Dexamethasone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Entacapone—Asthenia—Prednisone—ankylosing spondylitis	0.000983	0.000983	CcSEcCtD
Entacapone—Pain—Methotrexate—ankylosing spondylitis	0.000979	0.000979	CcSEcCtD
Entacapone—Pruritus—Prednisone—ankylosing spondylitis	0.000969	0.000969	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Entacapone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000936	0.000936	CcSEcCtD
Entacapone—Nausea—Dexamethasone—ankylosing spondylitis	0.000934	0.000934	CcSEcCtD
Entacapone—Nausea—Betamethasone—ankylosing spondylitis	0.000934	0.000934	CcSEcCtD
Entacapone—Urticaria—Methotrexate—ankylosing spondylitis	0.000909	0.000909	CcSEcCtD
Entacapone—Dizziness—Prednisone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000905	0.000905	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000905	0.000905	CcSEcCtD
Entacapone—Vomiting—Prednisone—ankylosing spondylitis	0.000871	0.000871	CcSEcCtD
Entacapone—Rash—Prednisone—ankylosing spondylitis	0.000864	0.000864	CcSEcCtD
Entacapone—Dermatitis—Prednisone—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Entacapone—Headache—Prednisone—ankylosing spondylitis	0.000858	0.000858	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000843	0.000843	CcSEcCtD
Entacapone—Asthenia—Methotrexate—ankylosing spondylitis	0.000821	0.000821	CcSEcCtD
Entacapone—Nausea—Prednisone—ankylosing spondylitis	0.000814	0.000814	CcSEcCtD
Entacapone—Pruritus—Methotrexate—ankylosing spondylitis	0.00081	0.00081	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Entacapone—Dizziness—Methotrexate—ankylosing spondylitis	0.000757	0.000757	CcSEcCtD
Entacapone—Vomiting—Methotrexate—ankylosing spondylitis	0.000728	0.000728	CcSEcCtD
Entacapone—Rash—Methotrexate—ankylosing spondylitis	0.000722	0.000722	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000721	0.000721	CcSEcCtD
Entacapone—Headache—Methotrexate—ankylosing spondylitis	0.000717	0.000717	CcSEcCtD
Entacapone—Nausea—Methotrexate—ankylosing spondylitis	0.00068	0.00068	CcSEcCtD
